Hannah Loftus

Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials

Adem Y. Dawed, Andrea Mari, Andrew Brown et al. · The Lancet Diabetes & Endocrinology · 2022 · 105 citations · Full text

Medicine, Endocrinology, Pharmacology +13

Design of experiment (DOE) applied to artificial neural network architecture enables rapid bioprocess improvement

Daniel Rodriguez-Granrose, Amanda K. Jones, Hannah Loftus et al. · Bioprocess and Biosystems Engineering · 2021 · 46 citations · Full text

Life Sciences, Bioengineering, Biotechnology +17

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Amr E. Abbas, Fatima Abbas et al. · The Lancet Diabetes & Endocrinology · 2023 · 40 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +11

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

Saul N. Faust, Richard Haynes, Christine E. Jones et al. · The Lancet Child & Adolescent Health · 2024 · 38 citations · Full text

Life Sciences, Immunology, Pediatrics +15